Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Marking Minute: How Presco Utilized PVC as PPE when the Coronavirus Pandemic Hit

You may know Presco for its barricade tape or marking flags, but a number of new customers got to know the company this year during the coronavirus pandemic. Presco quickly got up and running, creating personal protective equipment (PPE) solutions using PVC. John Yianitsas, Vice President of New Business Development at Presco, said PVC…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Marking Minute: How Presco Utilized PVC as PPE when the Coronavirus Pandemic Hit

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

You may know Presco for its barricade tape or marking flags, but a number of new customers got to know the company this year during the coronavirus pandemic.

Presco quickly got up and running, creating personal protective equipment (PPE) solutions using PVC.

John Yianitsas, Vice President of New Business Development at Presco, said PVC is a great fit when making PPE because it creates a tough-to-penetrate barrier, is easily cleanable, and can be either heat sealed or sewed. That gives users not only the opportunity to use PVC items more than once but also to utilize the material in a number of different ways.

“PVC can be used not only just for gowns, but drapes, barriers, and things like that, which is why I think it’s such a great product that can be used over and over again. It’s not a one-and-done,” Yianitsas said.

Few could say they saw a pandemic coming, so there was a rush to get PPE to those who needed it at the beginning of the pandemic. Luckily for those relying on Presco, the Texas-based company was able to turn around its products quickly since it was relying only on domestic materials and not waiting for supplies to arrive from abroad.

“I think the key factor in all this is the fact that we’re a domestic supplier. We source all our raw materials domestically, so we didn’t have to wait for anything to come in,” Yianitsas said. “Our ability to take an order and turn it around and fulfill it very, very quickly, the fact that we’re here in Sherman, Texas, gave us that opportunity to be able to respond very, very, quickly. Had we not had that capability, we would’ve been in the same boat as other people.”

Instead, Presco was able to help frontline workers in the United States do their job in a safe way, aiding the response when the country needed it most.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512